全文获取类型
收费全文 | 174859篇 |
免费 | 17022篇 |
国内免费 | 8108篇 |
专业分类
耳鼻咽喉 | 1080篇 |
儿科学 | 3110篇 |
妇产科学 | 2756篇 |
基础医学 | 39109篇 |
口腔科学 | 4653篇 |
临床医学 | 13784篇 |
内科学 | 21869篇 |
皮肤病学 | 3310篇 |
神经病学 | 10249篇 |
特种医学 | 3953篇 |
外国民族医学 | 47篇 |
外科学 | 22565篇 |
综合类 | 26582篇 |
现状与发展 | 36篇 |
一般理论 | 14篇 |
预防医学 | 6972篇 |
眼科学 | 3508篇 |
药学 | 17883篇 |
53篇 | |
中国医学 | 5336篇 |
肿瘤学 | 13120篇 |
出版年
2023年 | 1963篇 |
2022年 | 2632篇 |
2021年 | 5129篇 |
2020年 | 5327篇 |
2019年 | 4873篇 |
2018年 | 4944篇 |
2017年 | 5540篇 |
2016年 | 6316篇 |
2015年 | 6905篇 |
2014年 | 10784篇 |
2013年 | 13964篇 |
2012年 | 10106篇 |
2011年 | 11455篇 |
2010年 | 9519篇 |
2009年 | 9094篇 |
2008年 | 9372篇 |
2007年 | 9572篇 |
2006年 | 8860篇 |
2005年 | 7826篇 |
2004年 | 6820篇 |
2003年 | 5691篇 |
2002年 | 4583篇 |
2001年 | 3970篇 |
2000年 | 3361篇 |
1999年 | 2821篇 |
1998年 | 2365篇 |
1997年 | 2271篇 |
1996年 | 2107篇 |
1995年 | 2407篇 |
1994年 | 2163篇 |
1993年 | 1910篇 |
1992年 | 1633篇 |
1991年 | 1508篇 |
1990年 | 1248篇 |
1989年 | 1226篇 |
1988年 | 1036篇 |
1987年 | 907篇 |
1986年 | 775篇 |
1985年 | 1197篇 |
1984年 | 1055篇 |
1983年 | 729篇 |
1982年 | 859篇 |
1981年 | 687篇 |
1980年 | 559篇 |
1979年 | 459篇 |
1978年 | 375篇 |
1977年 | 265篇 |
1976年 | 264篇 |
1975年 | 129篇 |
1974年 | 100篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Effect of Replacement of Wharton Acellular Jelly With FBS on the Expression of Megakaryocyte Linear Markers in Hematopoietic Stem Cells CD34+ 下载免费PDF全文
zahra Jalili Behnam Emamgolizadeh Hossein Abbaszadeh Shahla JaliliMehdi Derakhshani Mehdi YousefiMehdi TalebiKarim Shams Asenjan Ali Akabr Movassaghpour 《Asian Pacific journal of cancer prevention》2022,23(10):3281-3286
Objective: Animal environments for the growth of stem cells cause the transmission of some diseases and immune problems for the recipient. Accordingly, replacing these environments with healthy environments, at least with human resources, is essential. One of the media that can be used as an alternative to animal serums is Wharton acellular jelly (AWJ). Therefore, in this study, we intend to replace FBS with Wharton jelly and investigate its effect on the expression of megakaryocyte-related genes and markers in stem cells. Materials and Methods: In this study, cord blood-derived CD34 positive HSCs were cultured and expanded in the presence of cytokines including SCF, TPO, and FLT3-L. Then, the culture of expanded CD34 positive HSCs was performed in two groups: 1) IMDM culture medium containing 10% FBS and 100 ng / ml thrombopoietin cytokine 2) IMDM culture medium containing 10% AWJ, 100 ng / ml thrombopoietin cytokine. Finally, CD41 expressing cells were analyzed with the flow cytometry method. The genes related to megakaryocyte lineage including FLI1 and GATA2 were also evaluated using the RT-PCR technique. Results: The expression of CD41, a specific marker of megakaryocyte lineage in culture medium containing Wharton acellular jelly was increased compared to the FBS group. Additionally, the expression of GATA2 and FLI1 genes was significantly increased related to the control group. Conclusion: This study provided evidence of differentiation of CD34 positive hematopoietic stem cells from umbilical cord blood to megakaryocytes in a culture medium containing AWJ. 相似文献
6.
外泌体是一类直径为30~100 nm的圆盘囊泡,其内包含许多组分,诸如复杂RNA和蛋白质等,主要参与细胞间的信号转导。肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)是肿瘤微环境中普遍存在的巨噬细胞,通过对肿瘤生长、免疫逃逸、侵袭和转移、耐药性等多方面的作用影响肿瘤进程。外泌体在肿瘤相关巨噬细胞的招募、极化及抗肿瘤免疫调控等方面发挥着重要的调节功能。同时,TAMs以外泌体为媒介作用于肿瘤细胞,从而构成了外泌体、TAMs与肿瘤细胞之间相互作用的调控通路。综上所述,本文旨在阐明肿瘤细胞与TAMs之间,以外泌体为“桥梁”相互影响的潜在机制,以及靶向肿瘤细胞和TAMs来源的外泌体在恶性肿瘤治疗中的展望。 相似文献
7.
8.
9.
Xi Tian Yue Wang Wenhao Xu Haidan Tang Shuxuan Zhu Aihetaimujiang Anwaier Wangrui Liu Wenfeng Wang Wenkai Zhu Jiaqi Su Yuanyuan Qu Hailiang Zhang Dingwei Ye 《International journal of cancer. Journal international du cancer》2023,152(1):66-78
In clear cell renal cell carcinoma (ccRCC), glycolysis is enhanced mainly because of the increased expression of key enzymes in glycolysis. Hence, the discovery of new molecular biomarkers for glycolysis may help guide and establish a precise system of diagnosis and treatment for ccRCC. Expression profiles of 1079 tumor samples of ccRCC patients (including 311 patients treated with everolimus or nivolumab) were downloaded from public databases. Proteomic profiles of 232 ccRCC samples were obtained from Fudan University Shanghai Cancer Center (FUSCC). Biological changes, tumor microenvironment and prognostic differences were explored between samples with various glycolysis characteristics. There were significant differences in CD8+ effector T cells, epithelial-to-mesenchymal transition and pan-fibroblast TGFb between the Low and High glyScore groups. The tumor mutation burden of the Low glyScore group was lower than that of the High glyScore group. And higher glyScore was significantly associated with worse overall survival (OS) in 768 ccRCC patients (P < .0001). External validation in FUSCC cohort also indicated that glyScore was of strong ability for predicting OS (P < .05). GlyScore may serve as a biomarker for predicting everolimus response in ccRCC patients due to its significant associations with progression-free survival (PFS). And glyScore may also predict overall survival in patients treated with nivolumab. We calculated the glyScore in ccRCC and the defined glyScore was of strong ability for predicting OS. In addition, glyScore may also serve as a biomarker for predicting PFS in patients treated with everolimus and could predict OS in patients treated with nivolumab. 相似文献
10.